NRXP — NRX Pharmaceuticals Share News
0.000.00%
Last trade - 00:00- $107.81m
- $81.53m
- $1.23m
NRX Pharmaceuticals Inc expected to post a loss of 14 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Energy firms, crypto stocks, Walt Disney
U.S. STOCKS ON THE MOVE-Cyclerion, banks, Jounce Therapeutics
NRx Pharma up on DSMB recommendation to continue enrollment for depression drug
Brief: NRx Pharmaceuticals Announces Positive Recommendation To Continue Enrollment In The Ongoing Trial Of NRX-101 In Patients With Suicidal Treatment-Resistant Bipolar Depression
Brief: NRX Pharmaceuticals Informs Investors Of No Assets With Silicon Valley Bank
Brief: NRX Pharma Receives U.S. Patent Covering NRX-101
U.S. STOCKS ON THE MOVE-Ralph Lauren, Howmet, Insulet
U.S. STOCKS ON THE MOVE-Top Ships, Brightcove, Airbnb
NRx Pharma rises as FDA suggests broadening scope of bipolar disorder drug trial
U.S. STOCKS ON THE MOVE-Arrow Electronics, fintechs, Amazon.com,
U.S. STOCKS ON THE MOVE-Aptiv, NRx Pharma, Becton Dickinson
NRx Pharma rises as DSMB finds depression drug 'safe'
Brief: NRx Pharmaceuticals Reports Recommendations Of Data Safety Monitoring Board For Trial Of NRX-101
U.S. STOCKS ON THE MOVE-Walt Disney, Personalis, Netflix
U.S. STOCKS ON THE MOVE- NextDecade, Eli Lilly, Norwegian
U.S. STOCKS ON THE MOVE-Apple, Surmodics, Domino's
NRX Pharma rises on positive FDA feedback for bipolar disorder drug
Refile: BUZZ-U.S. STOCKS ON THE MOVE-Gold miners, Starbucks, ASLAN Pharma